Precision medicine in COPD: where are we and where do we need to go?

by Venkataramana K. Sidhaye, Kristine Nishida, Fernando J. Martinez
Published 2018-08-01

Role of macrolide therapy in chronic obstructive pulmonary disease

by Fernando J Martinez, Jeffrey L Curtis, Richard Albert
Published 2008-10-01

A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD

by Dave Singh, Fernando J. Martinez, Henrik Watz, Thomas Bengtsson, Brian T. Maurer
Published 2020-02-01

Barriers to antigen detection and avoidance in chronic hypersensitivity pneumonitis in the United States

by Kerri I. Aronson, Ronan O’Beirne, Fernando J. Martinez, Monika M. Safford
Published 2021-08-01

Focusing on outcomes: Making the most of COPD interventions

by Noreen M Clark, Julia A Dodge, Martyn R Partridge, Fernando J Martinez
Published 2008-10-01

Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease

by Adam T Comstock, Fernando J Martinez, MeiLan K Han, Tyler A Barreto, Umadevi S Sajjan
Published 2020-05-01

Efficacy and safety profile of xanthines in COPD: a network meta-analysis

by Mario Cazzola, Luigino Calzetta, Peter J. Barnes, Gerard J. Criner, Fernando J. Martinez, Alberto Papi, Maria Gabriella Matera
Published 2018-05-01

Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler dual therapies in patients with COPD: a sub-study of the ETHOS trial

by Klaus F. Rabe, Fernando J. Martinez, Dave Singh, Roopa Trivedi, Martin Jenkins, Patrick Darken, Magnus Aurivillius, Paul Dorinsky
Published 2021-08-01

Establishing content-validity of a disease-specific health-related quality of life instrument for patients with chronic hypersensitivity pneumonitis

by Kerri I. Aronson, Maha Ali, Evgeniya Reshetynak, Robert J. Kaner, Fernando J. Martinez, Monika M. Safford, Laura C. Pinheiro
Published 2021-01-01

Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial

by Klaus F. Rabe, David M. G. Halpin, MeiLan K. Han, Marc Miravitlles, Dave Singh, Lars Grönke, Florian Voß, Fernando J. Martinez
Published 2020-07-01

Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD

by Nicola A. Hanania, Alberto Papi, Antonio Anzueto, Fernando J. Martinez, Kimberly A. Rossman, Christy S. Cappelletti, Elizabeth A. Duncan, Jack S. Nyberg, Paul M. Dorinsky
Published 2020-04-01

Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF.

by Shanna L Ashley, Meng Xia, Susan Murray, David N O'Dwyer, Ethan Grant, Eric S White, Kevin R Flaherty, Fernando J Martinez, Bethany B Moore
Published 2016-01-01

The Presenilin-1 ΔE9 Mutation Results in Reduced γ-Secretase Activity, but Not Total Loss of PS1 Function, in Isogenic Human Stem Cells

by Grace Woodruff, Jessica E. Young, Fernando J. Martinez, Floyd Buen, Athurva Gore, Jennifer Kinaga, Zhe Li, Shauna H. Yuan, Kun Zhang, Lawrence S.B. Goldstein
Published 2013-11-01

Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a...

by Fernando J. Martinez, Brian J. Lipworth, Klaus F. Rabe, David J. Collier, Gary T. Ferguson, Sanjay Sethi, Gregory J. Feldman, Gerald O’Brien, Martin Jenkins, Colin Reisner
Published 2020-05-01

Serological Investigation of the Collagen Degradation Profile of Patients with Chronic Obstructive Pulmonary Disease or Idiopathic Pulmonary Fibrosis

by Diana J. Leeming, Jannie M. Sand, Mette J. Nielsen, Federica Genovese, Fernando J. Martinez, Cory M. Hogaboam, MeiLan K Han, Lloyd B. Klickstein, Morten A. Karsdal
Published 2012-01-01

Serological Investigation of the Collagen Degradation Profile of Patients with Chronic Obstructive Pulmonary Disease or Idiopathic Pulmonary Fibrosis

by Diana J. Leeming, Jannie M. Sand, Mette J. Nielsen, Federica Genovese, Fernando J. Martinez, Cory M. Hogaboam, MeiLan K Han, Lloyd B. Klickstein, Morten A. Karsdal
Published 2012-09-01

Changes in the lung microbiome following lung transplantation include the emergence of two distinct Pseudomonas species with distinct clinical associations.

by Robert P Dickson, John R Erb-Downward, Christine M Freeman, Natalie Walker, Brittan S Scales, James M Beck, Fernando J Martinez, Jeffrey L Curtis, Vibha N Lama, Gary B Huffnagle
Published 2014-01-01

Human CD56+ cytotoxic lung lymphocytes kill autologous lung cells in chronic obstructive pulmonary disease.

by Christine M Freeman, Valerie R Stolberg, Sean Crudgington, Fernando J Martinez, MeiLan K Han, Stephen W Chensue, Douglas A Arenberg, Catherine A Meldrum, Lisa McCloskey, Jeffrey L Curtis
Published 2014-01-01

A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis.

by Sameer R Oak, Lynne Murray, Athula Herath, Matthew Sleeman, Ian Anderson, Amrita D Joshi, Ana Lucia Coelho, Kevin R Flaherty, Galen B Toews, Darryl Knight, Fernando J Martinez, Cory M Hogaboam
Published 2011-01-01

Basal gene expression by lung CD4+ T cells in chronic obstructive pulmonary disease identifies independent molecular correlates of airflow obstruction and emphysema extent.

by Christine M Freeman, Alexandra L McCubbrey, Sean Crudgington, Joshua Nelson, Fernando J Martinez, MeiLan K Han, George R Washko, Stephen W Chensue, Douglas A Arenberg, Catherine A Meldrum, Lisa McCloskey, Jeffrey L Curtis
Published 2014-01-01